Literature DB >> 12243791

Bacterial peritonitis in hepatic inferior vena cava disease: a hypothesis to explain the cause of infection in high protein ascites.

Santosh Shrestha1, Shobhana Shrestha.   

Abstract

Hepatic IVC disease (HVD), a disease caused by complete obstruction or stenosis of inferior vena cava (IVC) near cava-atrial junction is endemic in Nepal. It is a chronic disease characterized by upper abdominal pain, hepatomegaly, splenomegaly and dilated superficial veins in the body trunk. Ascites commonly, with high protein content is a feature of acute and subacute stages and during acute exacerbation of the chronic disease. We assessed the occurrence of bacterial peritonitis among patients of HVD with ascites. One hundred and sixty seven consecutive patients with ascites, which included 91 patients with HVD were examined for the presence of bacterial peritonitis. The ascitic fluids were examined for total and differential WBC count. The fluid and the blood were cultured for aerobic microorganisms by bedside inoculation in blood culture bottles. HVD is a common cause of non-cirrhotic high protein content ascites in Nepal. It was uniquely associated with high incidence of bacteremia (61%) and high incidence of mono-bacterial peritonitis (67%) from Gram-negative enteric bacteria (58.5%) and Staphylococcus aureus (42.5%). Ascites and bacterial peritonitis generally occurred almost simultaneously in these patients. It is postulated that when bacteremia occurred the defective portion of IVC near the cava-atrial junction become infected resulting in hepatic venous outflow obstruction and formation of ascites with high protein content. And spread of infection from the infected IVC to the peritoneum resulted in bacterial peritonitis.

Entities:  

Year:  2002        PMID: 12243791     DOI: 10.1016/s1386-6346(02)00018-9

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

Review 1.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

2.  Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report.

Authors:  Yusaku Shirai; Hitoshi Yoshiji; Saiho Ko; Masaharu Yamazaki; Yasuhide Ikenaka; Ryuichi Noguchi; Chie Morioka; Kosuke Kaji; Yosuke Aihara; Keisuke Nakanishi; Junichi Yamao; Masahisa Toyohara; Akira Mitoro; Masayoshi Sawai; Motoyuki Yoshida; Masao Fujimoto; Masahito Uemura; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  J Med Case Rep       Date:  2011-03-29

3.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

4.  Splenomegaly and hypersplenism in hepatic vena cava syndrome.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Forum       Date:  2021-05-24

5.  Inferior vena cava thrombosis in young adults--a review of two cases.

Authors:  Barry J McAree; Mark E O'Donnell; Chris Boyd; Roy Aj Spence; Bernard Lee; Chee V Soong
Journal:  Ulster Med J       Date:  2009-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.